Rovatti Ilaria, Di Girolamo Nicola, Scarabelli Stefania
Clinica Veterinaria Malpensa-Anicura, Samarate, Varese, Italy.
Department of Clinical Sciences, Cornell University, Ithaca, NY, USA.
Vet Anaesth Analg. 2024 Sep-Oct;51(5):500-509. doi: 10.1016/j.vaa.2024.07.004. Epub 2024 Jul 11.
To assess whether adding metoclopramide to a protocol of maropitant and pantoprazole would reduce incidence of ptyalism, vomiting and regurgitation in brachycephalic dogs undergoing thoracolumbar spinal surgery.
Randomized blinded controlled trial.
A total of 43 brachycephalic dogs undergoing thoracolumbar spinal surgery.
In addition to a standardized anaesthetic regimen, dogs were randomized to be administered either a 2 mg kg day metoclopramide constant rate infusion (CRI) or a saline solution at an equivalent infusion rate, started after anaesthetic induction and discontinued 5 hours after tracheal extubation. The presence of vomiting, regurgitation and pytalism, and short form of the Glasgow Composite Pain Scale pain scores were assessed by a blinded observer hourly for 4 hours, starting 1 hour postextubation.
Regurgitation occurred in six dogs postoperatively; three dogs were in the placebo group and three in the metoclopramide group. The odds ratio (OR) of regurgitation after surgery did not differ between groups [OR: 0.76, 95% confidence interval (CI): 0.13-4.3, p = 0.76]. The odds of observing ptyalism at 3 and 4 hours was approximately 15 times less than 1 hour postoperatively (both OR: 15.4, 95% CI: 1.8-130.7, p = 0.012) and did not differ based on the addition of metoclopramide (OR: 0.73, 95% CI: 0.07-8.0, p = 0.79). The odds of observing pain did not change over time and did not differ based on the addition of metoclopramide (OR: 0.71, 95% CI: 0.12-4.2, p = 0.71). Vomiting did not occur during the study (0.0%, 95% CI: 0.0-8.2%). No adverse effects were observed during the study period in either group.
The addition of a metoclopramide CRI to maropitant and pantoprazole did not result in a significant reduction in ptyalism or regurgitation in brachycephalic dogs undergoing thoracolumbar spinal surgery.
评估在使用马罗匹坦和泮托拉唑的方案中添加甲氧氯普胺是否会降低接受胸腰椎脊柱手术的短头犬流涎、呕吐和反流的发生率。
随机双盲对照试验。
共有43只接受胸腰椎脊柱手术的短头犬。
除了标准化的麻醉方案外,犬被随机分为两组,一组以2毫克/千克/天的剂量持续静脉输注甲氧氯普胺,另一组以相同的输注速率输注生理盐水,在麻醉诱导后开始,气管拔管后5小时停止。由一名盲法观察者在拔管后1小时开始,每小时评估4小时,观察呕吐、反流和流涎的情况,以及格拉斯哥综合疼痛量表简表的疼痛评分。
术后有6只犬出现反流;安慰剂组和甲氧氯普胺组各有3只。两组术后反流的优势比(OR)无差异[OR:0.76,95%置信区间(CI):0.13 - 4.3,p = 0.76]。术后3小时和4小时观察到流涎的几率比术后1小时约低15倍(两者OR:15.4,95%CI:1.8 - 130.7,p = 0.012),且添加甲氧氯普胺后无差异(OR:0.73,95%CI:0.07 - 8.0,p = 0.79)。观察到疼痛的几率随时间未发生变化,且添加甲氧氯普胺后无差异(OR:0.71,95%CI:0.12 - 4.2,p = 0.71)。研究期间未发生呕吐(0.0%,95%CI:0.0 - 8.2%)。两组在研究期间均未观察到不良反应。
在接受胸腰椎脊柱手术的短头犬中,在马罗匹坦和泮托拉唑方案中添加甲氧氯普胺持续静脉输注并未显著降低流涎或反流的发生率。